Thats the thing most men get wrong: they treat GLP-1 as the solution instead of as the window
Researchers are specifically proposing BPC-157 as a treatment for cancer patients
Then there is oral semaglutide (Rybelsus), which belongs to the GLP-1 family just like the injections but is currently FDA-approved for type 2 diabetes, not weight management
Third, MR estimates, although less confounded, are less precise than conventional observational studies, because the genetic variants only explain a small proportion of the variance in exposure [38]
January 1, 2026 Update: The court overseeing the GLP-1 drug MDL signaled that allegations linking Ozempic, Wegovy, and similar medications to gastroparesis and severe gastrointestinal injuries will remain a central focus of proceedings in 2026
While semaglutide is primarily used to treat patients with Type II diabetes, non-diabetics with a BMI of over 30, or whose health is directly affected by their weight, can still take semaglutide for weight loss